Free Trial
NASDAQ:IVA

Inventiva (IVA) Stock Price, News & Analysis

Inventiva logo
$6.53 +0.23 (+3.65%)
Closing price 10/3/2025 04:00 PM Eastern
Extended Trading
$6.59 +0.06 (+0.92%)
As of 10/3/2025 06:32 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Inventiva Stock (NASDAQ:IVA)

Advanced

Key Stats

Today's Range
$6.26
$6.55
50-Day Range
$3.04
$6.53
52-Week Range
$1.60
$6.55
Volume
112,843 shs
Average Volume
59,005 shs
Market Capitalization
$624.66 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$15.57
Consensus Rating
Moderate Buy

Company Overview

Inventiva Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
67th Percentile Overall Score

IVA MarketRank™: 

Inventiva scored higher than 67% of companies evaluated by MarketBeat, and ranked 338th out of 941 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Inventiva has received a consensus rating of Moderate Buy. The company's average rating score is 2.63, and is based on 6 buy ratings, 1 hold rating, and 1 sell rating.

  • Upside Potential

    Inventiva has a consensus price target of $15.57, representing about 138.5% upside from its current price of $6.53.

  • Amount of Analyst Coverage

    Inventiva has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Inventiva's stock forecast and price target.
  • Earnings Growth

    Earnings for Inventiva are expected to grow in the coming year, from ($2.08) to ($1.85) per share.

  • Percentage of Shares Shorted

    0.07% of the outstanding shares of Inventiva have been sold short.
  • Short Interest Ratio / Days to Cover

    Inventiva has a short interest ratio ("days to cover") of 1.6, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Inventiva has recently increased by 50.57%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Inventiva does not currently pay a dividend.

  • Dividend Growth

    Inventiva does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.07% of the outstanding shares of Inventiva have been sold short.
  • Short Interest Ratio / Days to Cover

    Inventiva has a short interest ratio ("days to cover") of 1.6, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Inventiva has recently increased by 50.57%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Inventiva has a news sentiment score of 0.25. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.53 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 14 news articles for Inventiva this week, compared to 3 articles on an average week.
  • Search Interest

    23 people have searched for IVA on MarketBeat in the last 30 days. This is an increase of 475% compared to the previous 30 days.
  • MarketBeat Follows

    2 people have added Inventiva to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Inventiva insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    32.00% of the stock of Inventiva is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 19.06% of the stock of Inventiva is held by institutions.

  • Read more about Inventiva's insider trading history.
Receive IVA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Inventiva and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

IVA Stock News Headlines

Inventiva management to meet with Piper Sandler
Tilson: “I’m watching HOOD”
A strange chasm is coming to Wall Street... It's already creating millionaires and billionaires at the fastest pace in history. CNBC calls it "the largest wealth creation spree in history." Yet 1 in 3 Americans now fear their financial situation is deteriorating. There's only one way to survive, says the man who predicted 2008 and 2020, but sadly it's already too late for many.tc pixel
Inventiva Appoints Andrew Obenshain as Chief Executive Officer
Inventiva (NASDAQ:IVA) Given Buy Rating at Canaccord Genuity Group
See More Headlines

IVA Stock Analysis - Frequently Asked Questions

Inventiva's stock was trading at $2.14 on January 1st, 2025. Since then, IVA stock has increased by 205.1% and is now trading at $6.53.

Inventiva (IVA) raised $103 million in an IPO on Friday, July 10th 2020. The company issued 7,500,000 shares at $13.68 per share. Jefferies, Stifel and Guggenheim Securities acted as the underwriters for the IPO and H.C. Wainwright, Roth Capital Partners and KBC Securities were co-managers.

Shares of IVA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Inventiva investors own include Kinross Gold (KGC), Oncobiologics (OTLK), Accuray (ARAY), Carnival (CCL), Alibaba Group (BABA), PayPal (PYPL).

Company Calendar

Today
10/03/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:IVA
CIK
1756594
Fax
N/A
Employees
100
Year Founded
2011

Price Target and Rating

High Price Target
$26.00
Low Price Target
$3.00
Potential Upside/Downside
+138.5%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.86
Research Coverage
7 Analysts

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
$9.95 million
Price / Sales
62.78
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($1.21) per share
Price / Book
-5.40

Miscellaneous

Outstanding Shares
95,660,000
Free Float
65,050,000
Market Cap
$624.66 million
Optionable
Not Optionable
Beta
0.66

Social Links

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (NASDAQ:IVA) was last updated on 10/4/2025 by MarketBeat.com Staff
From Our Partners